Location History:
- Vernon Hills, IL (US) (1995)
- Buffalo Grove, IL (US) (2008)
Company Filing History:
Years Active: 1995-2008
Title: Inventor Stephen C. Hsu: Innovations in Immunoassay Techniques
Introduction
Stephen C. Hsu is a notable inventor based in Buffalo Grove, Illinois, known for his contributions to the field of immunology through innovative patent developments. With a focus on enhancing immunoassay techniques, he has significantly advanced the methodology for determining antibody avidity.
Latest Patents
Stephen C. Hsu holds two patents in the realm of immunology. His latest inventions include:
1. **Methods for the determination of antibody IgG avidity** - This invention pertains to methods for assessing anti-infectious agent IgG avidity, particularly focusing on human anti-cytomegalovirus and human anti-toxoplasma IgG avidity, employing a competitive assay format.
2. **Folate immunoassay utilizing folate binding protein in a multiclonal** - This patent describes an improved method for conducting immunoassays featuring specific binding proteins for vitamin B12, folate, and other target analytes. The technique utilizes antibodies with varying specificities for binding proteins, allowing antibodies to connect the specific binding protein, either directly or indirectly, to a capturable material.
Career Highlights
Stephen C. Hsu is associated with Abbott Laboratories Corporation, a leading global healthcare company where his work significantly contributes to medical diagnostics and therapeutic solutions. His expertise has placed him at the forefront of immunological advancements.
Collaborations
Throughout his career, Stephen has collaborated with esteemed colleagues, including Michael J. Beggs and Linda J. Sohn. These partnerships have fostered innovative approaches and novel solutions in their respective fields.
Conclusion
Through his inventive spirit and collaborative efforts, Stephen C. Hsu continues to make strides in immunology, particularly through his patented methodologies that enhance the accuracy and efficiency of immunoassays. His work exemplifies the important intersection of innovation and medical science, paving the way for future advancements in healthcare technology.